AI Designs Proteins: The Future of Medicine?

AI vs. Aging: OpenAI's new AI, GPT-4b micro, has redesigned proteins to rejuvenate cells, boosting stem cell markers and DNA repair in lab tests. Could this be a breakthrough for regenerative medicine, offering faster, more efficient treatments for diseases and aging? While challenges remain, this marks a leap towards AI-designed therapies. Hosted on Acast. See acast.com/privacy for more information.